The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS

Developing variant vaccines or multivalent vaccines is a feasible way to address the epidemic as the SARS-CoV-2 variants of concern (VOCs) posed an increased risk to global public health. The spike protein of the SARS-CoV-2 virus was usually used as the main antigen in many types of vaccines to prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kangwei, Sun, Huang, Wang, Kaiqin, Quan, Yaru, Qiao, Zhizhong, Hu, Yaling, Li, Changgui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224489/
https://www.ncbi.nlm.nih.gov/pubmed/37243106
http://dx.doi.org/10.3390/vaccines11051002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224489/
https://www.ncbi.nlm.nih.gov/pubmed/37243106
http://dx.doi.org/10.3390/vaccines11051002

Ejemplares similares